CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Crittenton Hospital Medical Center

Crittenton Hospital Medical Center is dedicated to enhancing the health status of the individuals that it serves.

Absolute Resource Solutions

Absolute Resource Solutions is a Flanders, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SouthStar Health Group

SouthStar Health Group is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wesana Health

Wesana Health helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and patent-pending protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model.

AmeriWaste Medical Services

AmeriWaste Medical Services is a Lakewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.